Find a Provider
Henry T. Tsai, MD
There are 17 Clinical Trials currently being conducted by Henry T. Tsai, MD
Title
Type
Enrollment
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma
Cancer
Open
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Cancer
Open
A022102: mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Cancer
Open
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Cancer
Open
CompassHER2: T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial
Cancer
Open
Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study
Cancer
Closed
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Cancer
Closed
A032101: Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)
Cancer
Closed
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Cancer
Closed
Study of Personalized Cancer Therapy to Determine Response and Toxicity. UCSD-HRPP-130794
Cancer
Open
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Cancer
Closed
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
Cancer
Open
Breast Cancer WEight Loss Study (BWEL Study)
Cancer
Closed
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Cancer
Open
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Cancer
Open
NRG-GI008 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)
Cancer
Open
S2209-A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance
Cancer
Open
LIVE
